TOKYO–(BUSINESS WIRE)–JSR is proud to announce that it completed the acquisition of Corvallis, OR-based Inpria Corporation on Oct. 29, making it a wholly owned subsidiary of JSR. Inpria, now a JSR company, is a world leader in metal oxide photoresist design, development and manufacturing for extreme ultraviolet (EUV) lithography.
Inpria will immediately begin integrating into the JSR family but will retain the name Inpria at this time and remain headquartered in Oregon, effectively expanding JSR�s Oregon footprint to three locations. JSRs General Manager of Advanced Lithography Material Business Promotion Department and Corporate Officer, Toru Kimura, will lead the integration and EUV expansion efforts.
Toru spent several years leading JSRs Yokkaichi R&D Center and working closely with global customers and consortia including imec in Belgium. Prior to his current role, Toru served as CTO.
The implementation of EUV technology is on the rise, specifically in the most advanced lithography processes at leading-edge semiconductor manufacturing sites and the acquisition of Inpria positions JSR to address a broader set of customer needs.
About JSR Corporation
JSR Corporation is a research-oriented, multinational company focused on the digital solutions, including semiconductor, and life sciences markets. Headquartered in Tokyo, Japan, JSR has facilities and offices throughout Asia, Europe and the US. JSRs customer-centric approach pursues sustainability and resilience through close collaborations, all with a focus on driving innovation to provide value to the worlds leading-edge industries. For more information about JSR Corporation, please visit www.jsr.co.jp.
Contacts
Missy Bindseil
JSR Micro, Inc.
830-237-9527
mbindseil@jsrmicro.com
VANCOUVER--(BUSINESS WIRE)--Capstone Copper Corp. (“Capstone” or the “Company”) (TSX:CS) (ASX:CSC) announced the voting results from…
DUBLIN--(BUSINESS WIRE)--The "Indonesia International Remittance Market Business and Investment Opportunities - Analysis by Transaction Value…
KCAS Bio continues to expand its global reach and has selected Crux Biolabs (Melbourne, Australia)…
Strengthens end-to-end RCM offering to healthcare providers Expands service capabilities to US physicians’ practices, and…
SINGAPORE - Media OutReach Newswire - 3 May 2024 - UPCX (UPC), a developer of…
DUBLIN--(BUSINESS WIRE)--The "China Biological Reagents Market (Molecular Biology Reagents, Proteins and Cell Reagents): Insights &…